Effectiveness of Saccharomyces boulardii and Metronidazole for Small Intestinal Bacterial Overgrowth in Systemic Sclerosis.

Grettel García-Collinot Eduardo Osiris Madrigal-Santillán Michel A Martínez-Bencomo Rosa A Carranza-Muleiro Luis Javier Jara-Quezada Olga Lidia Vera-Lastra Daniel Héctor Montes-Cortés Gabriela Medina María Del Pilar Cruz-Domínguez

Published in: Digestive diseases and sciences (2019)

Metronidazole treatment is partially effective in SIBO, but S. boulardii in monotherapy or in combination improves the gastrointestinal outcomes in SSc.

Keyphrases

systemic sclerosis
interstitial lung disease
combination therapy
randomized controlled trial
systematic review
type diabetes
open label
adipose tissue
insulin resistance
weight loss